Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing as New Actors in Hypercoagulability
In order to comprehensively expose cancer-related biochemical changes, we compared the platelet proteome of two types of cancer with a high risk of thrombosis (22 patients with brain cancer, 19 with lung cancer) to 41 matched healthy controls using unbiased two-dimensional differential in-gel electr...
Main Authors: | Huriye Ercan, Lisa-Marie Mauracher, Ella Grilz, Lena Hell, Roland Hellinger, Johannes A. Schmid, Florian Moik, Cihan Ay, Ingrid Pabinger, Maria Zellner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2260 |
Similar Items
-
Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation
by: Lena Hell, et al.
Published: (2021-03-01) -
Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis
by: Vassilios P. Memtsas, et al.
Published: (2021-02-01) -
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
by: Cornelia Englisch, et al.
Published: (2022-12-01) -
Application value of combined coagulation function indicators in monitoring hypercoagulable state of patients with colorectal cancer after chemotherapy
by: LU Yue, LU Renquan, ZHANG Jie, ZHENG Hui
Published: (2024-03-01) -
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
by: Michał Ząbczyk, et al.
Published: (2021-02-01)